Literature DB >> 35226124

Magnetic resonance imaging findings of pure prostatic ductal adenocarcinomas: a case series.

Hiromi Edo1, Yasuyo Urase2, Yoshiko Ueno2, Ayumu Kido3, Tsutomu Tamada3, Yudai Asano4, Kentaro Ida4, Hisataka Ito5, Takashi Koyama6, Kosuke Miyai7, Hitoshi Tsuda8, Hiroshi Shinmoto9.   

Abstract

PURPOSE: This study aimed to investigate the characteristics of magnetic resonance imaging (MRI) findings in pure prostatic ductal adenocarcinoma.
METHODS: From January 2009 to February 2020, seven patients who were diagnosed with pure prostatic ductal adenocarcinoma and had a referable preoperative MRI scan were included in the study. We evaluated the following MRI findings for each tumor: size, location, presence of multi-cystic component, and apparent diffusion coefficient (ADC) value.
RESULTS: The median maximum diameter of the tumors was 22 mm (range 19-70 mm). Regarding transverse distribution, five tumors were located in the periurethral area and two were located peripherally apart from the urethra. Two of the seven tumors had cystic components. The median ADC value of the tumors was 0.754 × 10-3 mm2/s (range 0.570-0.963 × 10-3 mm2/s). Based on the transverse distribution and components of the tumors on MRI, ductal adenocarcinomas were classified into three types: type I as a non-cystic tumor located peripherally apart from the urethra (29%, two cases); type II as a non-cystic tumor located in the periurethral area (43%, three cases); and type III as a tumor with a multi-cystic component (29%, two cases).
CONCLUSION: The non-cystic mass with periurethral distribution (type II) and multi-cystic mass (type III) may be characteristic features that differentiate pure ductal adenocarcinoma from ordinary acinar adenocarcinoma on MRI.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cystic component; Distribution; Ductal adenocarcinoma; Magnetic resonance imaging; Periurethral; Prostate

Mesh:

Year:  2022        PMID: 35226124     DOI: 10.1007/s00261-022-03454-z

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  27 in total

1.  Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program.

Authors:  Joshua J Meeks; Lee C Zhao; John Cashy; Shilajit Kundu
Journal:  BJU Int       Date:  2011-08-24       Impact factor: 5.588

Review 2.  Histological variants of prostatic carcinoma and their significance.

Authors:  Peter A Humphrey
Journal:  Histopathology       Date:  2012-01       Impact factor: 5.087

3.  Prostatic adenocarcinoma of ductal origin.

Authors:  V E Dube; G M Farrow; L F Greene
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

4.  Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression.

Authors:  D A Brinker; S R Potter; J I Epstein
Journal:  Am J Surg Pathol       Date:  1999-12       Impact factor: 6.394

5.  Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: effect of percentage of the ductal component and associated grade of acinar adenocarcinoma.

Authors:  Ali Amin; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2011-04       Impact factor: 6.394

6.  Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen.

Authors:  Todd M Morgan; Christopher J Welty; Funda Vakar-Lopez; Daniel W Lin; Jonathan L Wright
Journal:  J Urol       Date:  2010-10-16       Impact factor: 7.450

Review 7.  Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management.

Authors:  Nithesh Ranasinha; Altan Omer; Yiannis Philippou; Eli Harriss; Lucy Davies; Ken Chow; Paolo M Chetta; Andrew Erickson; Timothy Rajakumar; Ian G Mills; Richard J Bryant; Freddie C Hamdy; Declan G Murphy; Massimo Loda; Christopher M Hovens; Niall M Corcoran; Clare Verrill; Alastair D Lamb
Journal:  BJUI Compass       Date:  2021-01-05

8.  Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens.

Authors:  Amanda H Seipel; Fredrik Wiklund; N Peter Wiklund; Lars Egevad
Journal:  Virchows Arch       Date:  2013-02-27       Impact factor: 4.064

9.  Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases.

Authors:  J I Epstein; J M Woodruff
Journal:  Cancer       Date:  1986-01-01       Impact factor: 6.860

10.  Prostatic adenocarcinoma with endometrioid features. Clinical, pathologic, and ultrastructural findings.

Authors:  D G Bostwick; R W Kindrachuk; R V Rouse
Journal:  Am J Surg Pathol       Date:  1985-08       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.